Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T12:44:36.551Z Has data issue: false hasContentIssue false

Determining loading kinetics of drug releasing degradable shape-memory polymers

Published online by Cambridge University Press:  13 February 2012

Christian Wischke
Affiliation:
Center for Biomaterial Development and Berlin-Brandenburg Center for Regenerative Therapies, Institute for Polymer Research, Helmholtz-Zentrum Geesthacht, Kantstr. 55, 14513 Teltow, Germany
Susi Steuer
Affiliation:
present address: Intervet Innovation GmbH, 55270 Schwabenheim, Germany
Andreas Lendlein
Affiliation:
Center for Biomaterial Development and Berlin-Brandenburg Center for Regenerative Therapies, Institute for Polymer Research, Helmholtz-Zentrum Geesthacht, Kantstr. 55, 14513 Teltow, Germany
Get access

Abstract

Modern concepts for biofunctional implants often comprise the controlled release of bioactive compounds to gain specific biofunctionalities. Here, amorphous and semi-crystalline copolyester-based shape-memory polymer (SMP) networks are reported as matrix for pharmaceutical applications. Drug loading of such crosslinked networks by swelling techniques requires tools to determine the actual payload. In this report, the capability of determining loading kinetics by mass increase or changes of drug concentration in the swelling medium is explored for two types of copolyester-based SMP networks differing in their crosslinking chemistry. Nitrofurantoin and ethacridine lactate served as hydrophobic and hydrophilic model drugs. It was found, that the absolute values of the determined payload did not systematically agree with those obtained by the more reliable technique of network cleavage and spectrophotometric quantification. However, the studies indicate that for both types of SMP materials and both drugs, maximum incorporation of the drugs occurred within a few hours. The time until equilibration depended on the network properties.

Type
Research Article
Copyright
Copyright © Materials Research Society 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Lendlein, A., Behl, M., Hiebl, B., and Wischke, C., Expert Review of Medical Devices, 7, 357 (2010).Google Scholar
2. Neffe, A.T., Hanh, B.D., Steuer, S., and Lendlein, A., Advanced Materials, 21, 3394 (2009).Google Scholar
3. Wischke, C., Neffe, A.T., Steuer, S., and Lendlein, A., European Journal of Pharmaceutical Sciences, 41, 136 (2010).Google Scholar
4. Wischke, C., Neffe, A.T., Steuer, S., Engelhardt, E., and Lendlein, A., Macromolecular Bioscience, 10, 1063 (2010).Google Scholar
5. Nagahama, K., Ueda, Y., Ouchi, T., and Ohya, Y., Biomacromolecules, 10, 1789 (2009).Google Scholar
6. Serrano, M.C., Carbajal, L., and Ameer, G.A., Advanced Materials, 23, 2211 (2011).Google Scholar
7. Wischke, C., Neffe, A.T., Steuer, S., and Lendlein, A., Journal of Controlled Release, 138, 243 (2009).Google Scholar
8. Budavari, S. (Ed.), Merck Index, 11th Edition, Merck&Co., Rahway, 1989.Google Scholar
9. Drug Bank database, http://www.drugbank.ca.Google Scholar